Subcomponent vaccine based on CTA1-DD adjuvant with incorporated UreB class II peptides stimulates protective Helicobacter pylori immunity. - Wikidata - wikimedia - TriplyDB

Subcomponent vaccine based on CTA1-DD adjuvant with incorporated UreB class II peptides stimulates protective Helicobacter pylori immunity.

Subcomponent vaccine based on CTA1-DD adjuvant with incorporated UreB class II peptides stimulates protective Helicobacter pylori immunity.

http://www.wikidata.org/entity/Q35082439

about

Roles and relevance of mast cells in infection and vaccination Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses Mechanisms of Cholera Toxin in the Modulation of TH17 Responses.Immunity, inflammation, and vaccines for Helicobacter pylori.The study of H. pylori putative candidate factors for single- and multi-component vaccine development.Mucosal adjuvants: Opportunities and challenges.Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.The influence of adjuvant on UreB protection against Helicobacter pylori through the diversity of CD4+ T-cell epitope repertoire.

P2860

Q26777264-5A9D300F-D71F-4B85-A8A4-A37B2F60719A Q26778023-F4E8C370-991D-418D-8FF1-15E92CAB8326 Q36120631-59C30EB2-BCD5-457B-BFE5-51B9FE34CDE0 Q36256348-C35B7E0E-958C-4C7B-A685-241CAA2FEC29 Q37641941-EFFE8FFF-756B-48F8-805C-58D8821D4892 Q38244254-5D3AFE01-0E9E-48E7-9E21-B33DFAE343B6 Q39350897-9861D0D4-81C2-4EE6-8E85-3FBE0A3E36E7 Q40682360-FA3E7684-95AA-4EBD-BE0E-6276559E517B Q41352677-215F0A3D-E71A-40B3-99C7-33816161A329 Q42366604-BDB8B601-954D-49AF-9D33-52975AE5DE1D

P2860

Subcomponent vaccine based on CTA1-DD adjuvant with incorporated UreB class II peptides stimulates protective Helicobacter pylori immunity.

http://www.wikidata.org/entity/Q35082439

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Subcomponent vaccine based on ...... Helicobacter pylori immunity.

@ast

Subcomponent vaccine based on ...... Helicobacter pylori immunity.

@en

type

label

Subcomponent vaccine based on ...... Helicobacter pylori immunity.

@ast

Subcomponent vaccine based on ...... Helicobacter pylori immunity.

@en

prefLabel

Subcomponent vaccine based on ...... Helicobacter pylori immunity.

@ast

Subcomponent vaccine based on ...... Helicobacter pylori immunity.

@en

P1433

Q35082439-0E7425BE-B94A-45B0-BB25-D410FD3CB632

P1476

Q35082439-1BD0ED1C-ADE2-44CE-907B-6CF63FB46F33

P2093

Q35082439-5DA9C406-DD5B-4064-8666-BD6344E170B6

Q35082439-88F7EB10-DA7B-4B98-92CD-BA7B62409AF4

Q35082439-8DEF5450-BBAF-4C42-954B-F1248CD2E2A4

Q35082439-C0716B0C-C2D5-4DAB-B426-2EB0159B35B7

Q35082439-D95DCC00-13F1-4B88-9488-0071E0EB3695

Q35082439-E6FFFD01-55D6-4E25-881F-A44DC2681AC3

P2860

Q35082439-04A3C8B6-3BB8-4FC8-AEB2-A8D1FF696CE2

Q35082439-0BA39515-ED7F-4376-82CC-D5DE5E8FB956

Q35082439-0C7C886A-99CA-4875-AFD5-2C70D2F2A2A5

Q35082439-20E14F47-6A37-4A6E-A8BA-EFF38FA6362A

Q35082439-255A1F09-3E76-4AC3-BDC3-A0B38EE500AB

Q35082439-2AE88E03-97FB-47AB-9F95-EEB00439028B

Q35082439-2C6DE0B4-AA1C-42A3-9BEE-EF59AAF56175

Q35082439-3F4B6976-6440-4D61-99B9-394A6B3C1E80

Q35082439-3FE7BDBB-4FCF-4F82-8378-6A7AA9B39741

Q35082439-50BBE074-B8EC-45BB-8E4D-D6AD616A9925

P304

Q35082439-2D61020B-0B0A-4408-8941-FE34801CB5F7

P31

Q35082439-8A255E5C-7ACE-4344-B23B-0FCE154E3505

P356

Q35082439-EA44556B-059C-4005-84E7-CF834AAA532D

P407

Q35082439-F2DE348D-47CD-4864-8E56-290328294166

P433

Q35082439-84DD423B-4002-4B79-9DB0-F4C4F1DB093D

P478

Q35082439-8A2E07F6-DBCE-4CFB-981E-28D1ED782316

P50

Q35082439-942C4768-0957-4913-8995-B4A95E12DF2A

P577

Q35082439-5602E056-BDB3-4F13-9469-FFAA2C7ACF04

P5875

Q35082439-6D026269-F406-481F-8EA2-005E384DE3B7

P698

Q35082439-457B9381-21C4-4404-8F3A-A3756E9765AE

P921

Q35082439-F03D2636-B296-40AF-979F-D65A3EDE76F1

P932

Q35082439-D05B0457-21D0-4D26-99BA-E3AA63A931DB

P356

JOURNAL.PONE.0083321

P1433

P1476

Subcomponent vaccine based on ...... Helicobacter pylori immunity.

@en

P2093

Dubravka Grdic Eliasson

http://www.w3.org/2001/XMLSchema#string

Hilda Bergroth

http://www.w3.org/2001/XMLSchema#string

John G Nedrud

http://www.w3.org/2001/XMLSchema#string

Karin Schön

http://www.w3.org/2001/XMLSchema#string

Nayer Bagheri

http://www.w3.org/2001/XMLSchema#string

Wei Xin

http://www.w3.org/2001/XMLSchema#string

P2860

Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.

A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus.

Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A.

Identification of an antigenic epitope in Helicobacter pylori urease that induces neutralizing antibody production.

Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin.

Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice

Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase.

Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent.

P304

e83321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0083321

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259588911

http://www.w3.org/2001/XMLSchema#string

P698

24391754

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori

P932

3877028

http://www.w3.org/2001/XMLSchema#string